Acute lymphoblastic leukemia secondary to myeloproliferative neoplasms or after lenalidomide exposure-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Acute lymphoblastic leukemia secondary to myeloproliferative neoplasms or after lenalidomide exposure

Published:2017-12-06 Issue:1 Volume:6 Page:155-161
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clin Case Rep

Author:

Alhuraiji Ahmad¹^ORCID,Naqvi Kiran¹,Huh Yang O.²,Ho Coty³,Verstovsek Srdan¹,Bose Prithviraj¹

Affiliation:

1. Department of Leukemia; University of Texas MD Anderson Cancer Center; Houston 77030 Texas

2. Department of Hematopathology; University of Texas MD Anderson Cancer Center; Houston 77030 Texas

3. Oklahoma Cancer Specialists and Research Institute; Tulsa 74133 Oklahoma

Funder

University of Texas MD Anderson Cancer Center

National Cancer Institute

Publisher

Wiley

Subject

General Medicine

Reference51 articles.

1. Myeloproliferative neoplasms: a contemporary review;Tefferi;JAMA Oncol.,2015

2. Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis;Rampal;Blood,2014

3. Janus kinase deregulation in leukemia and lymphoma;Chen;Immunity,2012

4. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia;Roberts;N. Engl. J. Med.,2014

5. Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm;Beer;Blood,2010

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Case of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with Coexistence of the JAK2V617F Clone;Turkish Journal of Hematology;2024-05-30

2. U2AF1 in various neoplastic diseases and relevant targeted therapies for malignant cancers with complex mutations (Review);Oncology Reports;2023-11-16

3. Acute myelofibrosis superseding B‐lymphoblastic leukemia/lymphoma;eJHaem;2023-08-08

4. Use of Next Generation Sequencing to Define the Origin of Primary Myelofibrosis;Cancers;2023-03-15

5. Treating accelerated and blast phase myeloproliferative neoplasms: progress and challenges;Therapeutic Advances in Hematology;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3